| Product Code: ETC7917786 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Latvia`s import shipments of PD-1 and PD-L1 inhibitors in 2024 continued to showcase a diverse sourcing pattern, with top exporters being Lithuania, Netherlands, Switzerland, Poland, and Germany. The low concentration of the Herfindahl-Hirschman Index (HHI) indicates a competitive market landscape. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a healthy 8.6%, demonstrating sustained growth in the sector. Furthermore, the growth rate from 2023 to 2024 was recorded at 7.03%, highlighting a positive trajectory for the import of these pharmaceutical products into Latvia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia PD-1 and PD-L1 Inhibitors Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia PD-1 and PD-L1 Inhibitors Market Revenues & Volume, 2022 & 2032F |
3.3 Latvia PD-1 and PD-L1 Inhibitors Market - Industry Life Cycle |
3.4 Latvia PD-1 and PD-L1 Inhibitors Market - Porter's Five Forces |
3.5 Latvia PD-1 and PD-L1 Inhibitors Market Revenues & Volume Share, By Inhibitors, 2022 & 2032F |
3.6 Latvia PD-1 and PD-L1 Inhibitors Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Latvia PD-1 and PD-L1 Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 Latvia PD-1 and PD-L1 Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Latvia |
4.2.2 Growing awareness about immunotherapy as a treatment option |
4.2.3 Favorable government initiatives and funding for cancer research and treatment |
4.3 Market Restraints |
4.3.1 High cost associated with pd-1 and pd-l1 inhibitors |
4.3.2 Limited access to advanced healthcare facilities in certain regions of Latvia |
5 Latvia PD-1 and PD-L1 Inhibitors Market Trends |
6 Latvia PD-1 and PD-L1 Inhibitors Market, By Types |
6.1 Latvia PD-1 and PD-L1 Inhibitors Market, By Inhibitors |
6.1.1 Overview and Analysis |
6.1.2 Latvia PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Inhibitors, 2022 - 2032F |
6.1.3 Latvia PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By PD-1 Inhibitors, 2022 - 2032F |
6.1.4 Latvia PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By PD-L1 Inhibitors, 2022 - 2032F |
6.2 Latvia PD-1 and PD-L1 Inhibitors Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Latvia PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Hodgkin Lymphoma, 2022 - 2032F |
6.2.3 Latvia PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Kidney Cancer, 2022 - 2032F |
6.2.4 Latvia PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Melanoma, 2022 - 2032F |
6.2.5 Latvia PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Non-small Cell Lung Cancer, 2022 - 2032F |
6.2.6 Latvia PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Other Applications, 2022 - 2032F |
6.3 Latvia PD-1 and PD-L1 Inhibitors Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Latvia PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Hospital Pharmacies, 2022 - 2032F |
6.3.3 Latvia PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Retail Pharmacies, 2022 - 2032F |
6.3.4 Latvia PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Online Pharmacies, 2022 - 2032F |
7 Latvia PD-1 and PD-L1 Inhibitors Market Import-Export Trade Statistics |
7.1 Latvia PD-1 and PD-L1 Inhibitors Market Export to Major Countries |
7.2 Latvia PD-1 and PD-L1 Inhibitors Market Imports from Major Countries |
8 Latvia PD-1 and PD-L1 Inhibitors Market Key Performance Indicators |
8.1 Number of clinical trials for pd-1 and pd-l1 inhibitors conducted in Latvia |
8.2 Adoption rate of immunotherapy in cancer treatment protocols |
8.3 Number of healthcare professionals trained in administering pd-1 and pd-l1 inhibitors |
9 Latvia PD-1 and PD-L1 Inhibitors Market - Opportunity Assessment |
9.1 Latvia PD-1 and PD-L1 Inhibitors Market Opportunity Assessment, By Inhibitors, 2022 & 2032F |
9.2 Latvia PD-1 and PD-L1 Inhibitors Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Latvia PD-1 and PD-L1 Inhibitors Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 Latvia PD-1 and PD-L1 Inhibitors Market - Competitive Landscape |
10.1 Latvia PD-1 and PD-L1 Inhibitors Market Revenue Share, By Companies, 2025 |
10.2 Latvia PD-1 and PD-L1 Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here